Literature DB >> 22637738

Different types of resistance training in type 2 diabetes mellitus: effects on glycaemic control, muscle mass and strength.

Andreas Egger1, David Niederseer, Gernot Diem, Thomas Finkenzeller, E Ledl-Kurkowski, Rosemarie Forstner, Christian Pirich, Wolfgang Patsch, Raimund Weitgasser, Josef Niebauer.   

Abstract

BACKGROUND: Resistance training has become a mainstay of exercise training in type 2 diabetes mellitus (T2DM). However, it remains controversial whether hypertrophy resistance training (HRT) is superior to endurance resistance training (ERT) with regard to its effects on glycaemic control, muscle mass and strength.
METHODS: Thirty-two patients with T2DM (13 men and 19 women; 64.8 ± 7.8 years) were randomly assigned to either eight weeks of HRT (n = 16; 2 sets, 10-12 repetitions, 70% of the one-repetition maximum (1-RM)) or ERT (n = 16; 2 sets, 25-30 repetitions, 40% 1-RM). In addition, all patients participated in aerobic exercise training (AET; 1 hour/day on 2 non-consecutive days/week; cycle ergometer; 70% of heart rate reserve).
RESULTS: After eight weeks of intervention, there were time but not group effects for reduced glucose and fructosamine levels, weight, BMI, waist circumference, subcutaneous abdominal fat, resting heart rate, systolic and diastolic blood pressure; muscle mass of the arms and physical exercise capacity increased significantly. Significant time and group effects were documented for maximum strength of the chest, with a greater increase for HRT than ERT (p = 0.01).
CONCLUSIONS: Specific maximal resistance training of the chest muscles led to superior gain in strength as compared to endurance resistance training. This, however, did not translate into superior values of glycaemic control, weight, waist circumference, muscle mass and physical work capacity, which all improved significantly by a similar magnitude in both groups. Since overall effects of both protocols were comparable, both may be offered to patients according to their personal preference.

Entities:  

Keywords:  Type 2 diabetes mellitus; glycaemic control; physical work capacity; resistance training; upper body strength

Mesh:

Substances:

Year:  2012        PMID: 22637738     DOI: 10.1177/2047487312450132

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  10 in total

1.  The relationship of fasting hyperglycemia to changes in fat and muscle mass after exercise training in type 2 diabetes.

Authors:  Swaytha V Yalamanchi; Kerry J Stewart; Nan Ji; Sherita H Golden; Adrian Dobs; Diane M Becker; Dhananjay Vaidya; Brian G Kral; Rita R Kalyani
Journal:  Diabetes Res Clin Pract       Date:  2016-10-10       Impact factor: 5.602

Review 2.  Exercise interventions in polypathological aging patients that coexist with diabetes mellitus: improving functional status and quality of life.

Authors:  Eduardo Lusa Cadore; Mikel Izquierdo
Journal:  Age (Dordr)       Date:  2015-06-09

Review 3.  Exercise and Nutrition Strategies for Combating Sarcopenia and Type 2 Diabetes Mellitus in Older Adults.

Authors:  Dionysia Argyropoulou; Nikolaos D Geladas; Tzortzis Nomikos; Vassilis Paschalis
Journal:  J Funct Morphol Kinesiol       Date:  2022-06-08

Review 4.  Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group.

Authors:  Dominique Hansen; Josef Niebauer; Veronique Cornelissen; Olga Barna; Daniel Neunhäuserer; Christoph Stettler; Cajsa Tonoli; Eugenio Greco; Robert Fagard; Karin Coninx; Luc Vanhees; Massimo F Piepoli; Roberto Pedretti; Gustavo Rovelo Ruiz; Ugo Corrà; Jean-Paul Schmid; Constantinos H Davos; Frank Edelmann; Ana Abreu; Bernhard Rauch; Marco Ambrosetti; Simona Sarzi Braga; Paul Beckers; Maurizio Bussotti; Pompilio Faggiano; Esteban Garcia-Porrero; Evangelia Kouidi; Michel Lamotte; Rona Reibis; Martijn A Spruit; Tim Takken; Carlo Vigorito; Heinz Völler; Patrick Doherty; Paul Dendale
Journal:  Sports Med       Date:  2018-08       Impact factor: 11.136

5.  Skeletal muscle and organ masses differ in overweight adults with type 2 diabetes.

Authors:  Lance E Davidson; David E Kelley; Stanley Heshka; John Thornton; F Xavier Pi-Sunyer; Lawrence Boxt; Ashok Balasubramanyam; Dympna Gallagher
Journal:  J Appl Physiol (1985)       Date:  2014-06-19

6.  Fasting plasma glucose and lipid profiles of diabetic patients improve with aerobic exercise training.

Authors:  Benjamin Asuako; Monday O Moses; Benjamin A Eghan; Peter A Sarpong
Journal:  Ghana Med J       Date:  2017-09

7.  Changes in health parameters in older lay volunteers who delivered a lifestyle-based program to frail older people at home.

Authors:  Igor Grabovac; Sandra Haider; Eva Winzer; Ali Kapan; Karin E Schindler; Christian Lackinger; Thomas E Dorner
Journal:  Wien Klin Wochenschr       Date:  2018-08-09       Impact factor: 1.704

8.  Decreased Appendicular Skeletal Muscle Mass is Associated with Poor Outcomes after ST-Segment Elevation Myocardial Infarction.

Authors:  Ryosuke Sato; Eiichi Akiyama; Masaaki Konishi; Yasushi Matsuzawa; Hiroyuki Suzuki; Chika Kawashima; Yuichiro Kimura; Kozo Okada; Nobuhiko Maejima; Noriaki Iwahashi; Kiyoshi Hibi; Masami Kosuge; Toshiaki Ebina; Stephan von Haehling; Stefan D Anker; Kouichi Tamura; Kazuo Kimura
Journal:  J Atheroscler Thromb       Date:  2020-03-05       Impact factor: 4.928

9.  Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients - a Randomized Controlled Trial.

Authors:  Daniela Bassi; Renata Gonçalves Mendes; Vivian Maria Arakelian; Flávia Cristina Rossi Caruso; Ramona Cabiddu; José Carlos Bonjorno Júnior; Ross Arena; Audrey Borghi-Silva
Journal:  Sports Med Open       Date:  2016-08-11

Review 10.  Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss.

Authors:  Richard Kirwan; Deaglan McCullough; Tom Butler; Fatima Perez de Heredia; Ian G Davies; Claire Stewart
Journal:  Geroscience       Date:  2020-10-01       Impact factor: 7.713

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.